Company Advagene Biopharma Co., Ltd.

Equities

6709

TW0006709009

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
23.55 ^TWD	+0.64%		-12.62%	-7.28%

11/04	Advagene Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Advagene Biopharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Advagene Biopharma Co., Ltd. is a Taiwan-based company mainly enagegd in the research and development of new drug products through its detoxified LT adjuvant technology platform. The products developed by the Company include nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy) and other vaccines. The detoxified LT adjuvant is genetically engineered to detoxify the heat-labile LT protein (or Escherichia coli heat-labile enterotoxin protein) produced by Escherichia coli.

Number of employees: 11

Managers	Title	Age	Since
Yu Shen Hsu CEO	Chief Executive Officer	-	01/15/01
Pi Jung Chen CHM	Chairman	-	17/14/17
Jung Tun Su AUD	Comptroller/Controller/Auditor	-	-
Chen Jung Li AUD	Comptroller/Controller/Auditor	-	27/20/27

Members of the board	Title	Age	Since
Yi Hsu Huang BRD	Director/Board Member	-	06/16/06
Wei Hsiu Wu BRD	Director/Board Member	-	06/18/06
Tzong Li Lee BRD	Director/Board Member	-	23/19/23
Pi Jung Chen CHM	Chairman	-	17/14/17
Yu Shen Hsu CEO	Chief Executive Officer	-	01/15/01
Chin Yi Hsiao BRD	Director/Board Member	-	06/18/06
Tsung Ming Li BRD	Director/Board Member	-	23/19/23
Lin Wei Weng BRD	Director/Board Member	-	23/19/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	53,380,000	27,704,299 ( 51.90 %)	0	51.90 %

Advagene Biopharma Co., Ltd.

6th Floor No. 308, Section 1, Neihu Road

114 44, Taipei

http://www.advagene.com.tw

address Advagene Biopharma Co., Ltd.(6709)

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
ADVAGENE BIOPHARMA CO., LTD.	-7.28%	38.72M
MODERNA, INC.	+17.96%	44.96B
LONZA GROUP AG	+48.77%	41.85B
IQVIA HOLDINGS INC.	+1.17%	42.65B
CELLTRION, INC.	-4.27%	29.04B
ICON PUBLIC LIMITED COMPANY	+11.42%	26.08B
ALNYLAM PHARMACEUTICALS, INC.	-21.39%	19.03B
BIO-TECHNE CORPORATION	+4.86%	12.75B
MEDPACE HOLDINGS, INC.	+27.29%	12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.50%	11.75B

Other Biotechnology & Medical Research